Pulmonary Fibrosis - Nursing Case Study
Pathophysiology
• Primary mechanism: In pulmonary fibrosis, repeated injury and chronic inflammation of the alveolar epithelium lead to aberrant wound healing. This results in excessive fibroblast proliferation and extracellular matrix deposition, causing thickened, stiff lung tissue and impaired gas exchange.
• Secondary mechanism: The transforming growth factor-beta (TGF-β) pathway is crucial in disease progression. It promotes fibroblast activation and collagen production, exacerbating fibrosis and further decreasing lung elasticity.
• Key complication: Progressive scarring reduces lung compliance, increasing the work of breathing and leading to respiratory insufficiency, which can significantly impact patients' quality of life and oxygenation.
Patient Profile
Demographics:
68-year-old female, retired school teacher
History:
• Key past medical history: Hypertension, Type 2 Diabetes, and a history of smoking (quit 10 years ago)
• Current medications: Lisinopril, Metformin, Prednisone, Esomeprazole
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Increasing shortness of breath and persistent dry cough
• Key symptoms: Fatigue, weight loss, mild chest pain, and occasional low-grade fever
• Vital signs: Blood pressure 140/85 mmHg, Heart rate 102 bpm, Respiratory rate 28 breaths per minute, Temperature 99.1°F, Oxygen saturation 89% on room air
Section 1
Change in Patient Status:
During her hospital stay, the patient experiences a noticeable decline in her respiratory status. Her shortness of breath intensifies, and she now requires supplemental oxygen via nasal cannula to maintain an oxygen saturation of 92%. Despite oxygen supplementation, her respiratory rate remains elevated at 30 breaths per minute, indicating increased work of breathing. Auscultation reveals bilateral fine crackles, more pronounced at the lung bases, suggesting progression of fibrotic changes. Additionally, the patient reports worsening fatigue and a feeling of tightness in her chest, which correlates with her elevated heart rate now consistently at 110 bpm.
Further lab tests show a decrease in arterial blood gas values, with a pH of 7.33, PaCO2 of 48 mmHg, and PaO2 of 55 mmHg, indicating respiratory acidosis with hypoxemia. These findings suggest that her pulmonary fibrosis is leading to impaired gas exchange and respiratory insufficiency. The elevated carbon dioxide levels reflect her inability to adequately ventilate and clear CO2, a complication often seen as lung compliance decreases.
Clinicians suspect the development of pulmonary hypertension as a complication of her chronic lung disease, driven by hypoxic vasoconstriction and increased vascular resistance in the pulmonary circulation. This secondary condition could further strain her cardiovascular system, contributing to her tachycardia and fatigue. The healthcare team discusses the potential need for additional interventions, such as non-invasive ventilation support or adjusting her current medications, to manage her deteriorating respiratory function and prevent further complications.
Section 2
New Complications:
As the patient's condition continues to decline, the healthcare team notes the development of new complications that further complicate her clinical picture. Echocardiography is performed to assess the suspected pulmonary hypertension, revealing elevated pulmonary artery pressures consistent with this diagnosis. This finding confirms that her chronic hypoxemia has precipitated increased resistance in the pulmonary vasculature, placing additional strain on the right side of her heart. Consequently, the patient is now showing signs of right-sided heart failure, including peripheral edema, jugular venous distension, and hepatomegaly. Her blood pressure remains stable but on the lower end of her baseline, at 100/60 mmHg, suggesting a potential compromise in cardiac output.
In addition to the cardiovascular complications, the patient begins to exhibit signs of acute exacerbation of her pulmonary fibrosis. Her cough becomes more productive with thick, white sputum, and her auscultation now reveals more pronounced crackles and occasional wheezing. A high-resolution CT scan of the chest is conducted, showing an increase in ground-glass opacities and reticular patterns, indicative of an acute inflammatory process superimposed on her fibrotic lung disease. These acute changes necessitate a re-evaluation of her treatment regimen, considering the potential introduction of corticosteroids to manage inflammation and slow the progression of fibrosis.
The healthcare team convenes to discuss the best course of action given these new developments. The patient's increasing respiratory distress and cardiovascular strain call for immediate adjustments. Options include optimizing her oxygen therapy, possibly escalating to a high-flow nasal cannula or non-invasive positive pressure ventilation to improve oxygenation and reduce the work of breathing. Additionally, the introduction of pulmonary vasodilators, such as phosphodiesterase inhibitors or endothelin receptor antagonists, is considered to alleviate pulmonary hypertension and support her cardiac function. The team emphasizes the importance of close monitoring for any further signs of deterioration, as timely interventions will be critical in managing her complex clinical situation and preventing progression to acute respiratory failure.
Section 3
Change in Patient Status:
Following the adjustments to her treatment regimen, the patient experiences a notable change in her clinical status. Despite the initiation of high-flow nasal cannula oxygen therapy, her respiratory distress persists. Her respiratory rate increases to 28 breaths per minute, and she shows signs of increasing fatigue. The patient's oxygen saturation struggles to remain above 88% even with maximum oxygen support, indicating a potential progression towards respiratory failure. Additionally, her heart rate escalates to 110 beats per minute, and she begins to experience episodes of confusion and restlessness, suggesting a decline in cerebral oxygenation due to worsening hypoxemia.
The healthcare team conducts a thorough reassessment, noting that her jugular venous distension has increased, and her peripheral edema has worsened, consistent with right-sided heart failure. Blood gas analysis reveals a pH of 7.32, PaCO2 of 52 mmHg, and PaO2 of 55 mmHg, confirming respiratory acidosis with hypoxemia. Laboratory results also show elevated brain natriuretic peptide (BNP) levels of 650 pg/mL, further indicating significant cardiac strain. Given these findings, the team decides to escalate care by considering the use of non-invasive positive pressure ventilation to improve her ventilation and oxygenation status. They also deliberate the cautious introduction of diuretics to manage her fluid overload while monitoring her blood pressure to avoid exacerbating her hypotension.
The patient's evolving condition underscores the complexity of her clinical situation, necessitating vigilant monitoring and timely intervention. The healthcare team remains attentive to her response to these interventions, prepared to adjust the management plan as needed. Their immediate goal is to stabilize her respiratory and cardiac status, recognizing that any delay could lead to rapid deterioration and necessitate more invasive measures. Through this dynamic and responsive approach, they aim to optimize her clinical outcomes and maintain her quality of life amidst the challenges posed by her advancing pulmonary fibrosis and associated complications.
Section 4
Response to Interventions:
Following the escalation of care, the healthcare team initiates non-invasive positive pressure ventilation (NIPPV) for the patient, aiming to improve her ventilation and oxygenation status. Within the first few hours of NIPPV, her oxygen saturation begins to stabilize, reaching 92%, and her respiratory rate decreases slightly to 24 breaths per minute. Despite these improvements, the patient continues to exhibit episodes of confusion, albeit less frequently, indicating ongoing cerebral hypoxemia. Her heart rate remains elevated at 105 beats per minute, suggesting sustained sympathetic stimulation due to respiratory distress and potential cardiac involvement.
In parallel, the cautious administration of diuretics is implemented to address her fluid overload. Over the next 12 hours, the patient experiences a reduction in peripheral edema and a slight decrease in jugular venous distension, indicating some relief of her right-sided heart failure symptoms. However, her blood pressure drops to 95/60 mmHg, prompting the team to carefully balance diuretic therapy to avoid further hypotension, which could compromise her already delicate hemodynamic status.
Despite these interventions, new laboratory results reveal worsening renal function, with creatinine levels rising to 2.2 mg/dL from a baseline of 1.5 mg/dL, indicative of acute kidney injury possibly secondary to diuretic therapy and reduced cardiac output. This development presents a new challenge for the healthcare team, requiring a delicate balance between managing her fluid status and protecting renal function. The need for vigilant monitoring and constant reassessment becomes paramount as the patient's condition remains precarious, necessitating a nuanced approach to her complex clinical picture. The team is now tasked with fine-tuning her treatment regimen to stabilize her respiratory, cardiac, and renal systems, recognizing that any misstep could precipitate a rapid decline.
Section 5
New Complications:
Over the next 24 hours, the patient’s condition develops further complications, challenging the healthcare team’s management strategy. Despite the initial stabilization with non-invasive positive pressure ventilation (NIPPV), the patient begins to exhibit signs of increasing respiratory distress, characterized by accessory muscle use and a respiratory rate that climbs back to 28 breaths per minute. Her oxygen saturation, although initially stable, now fluctuates between 88% and 90%, indicating a decline in effective ventilation. Arterial blood gas analysis reveals a pH of 7.32, PaCO2 of 55 mmHg, and PaO2 of 60 mmHg, indicative of acute on chronic respiratory acidosis, likely exacerbated by her underlying pulmonary fibrosis and potential diaphragm fatigue.
Concurrently, the patient’s renal function continues to deteriorate, with creatinine levels rising to 2.8 mg/dL, and urine output declining to less than 400 mL over 24 hours, suggesting oliguria. Her blood pressure remains low at 90/58 mmHg, complicating further diuretic use. The healthcare team faces a conundrum, needing to address her fluid status to ease her respiratory workload yet avoiding exacerbating her acute kidney injury. A decision is made to consult nephrology for potential renal replacement therapy options and to adjust her diuretic regimen, considering the use of vasopressors to support her blood pressure without compromising renal perfusion further.
Amid these developments, the patient becomes increasingly lethargic and disoriented, raising concerns about worsening cerebral hypoxemia or uremic encephalopathy. Neurological assessments reveal decreased responsiveness to verbal stimuli and a Glasgow Coma Scale score of 12. These changes necessitate a comprehensive reassessment of her neurological status and consideration of further diagnostic imaging to rule out potential intracranial pathology or other contributing factors. The situation underscores the complexity of her case, requiring integrated multidisciplinary collaboration to stabilize her multifaceted physiological derangements and prevent further deterioration.